KIMBERLY PRICHARD: Open Payments
NPI 1790847358 · LA VERGNE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 41 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Novo Nordisk Inc | 4 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Exact Sciences Corporation | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| CeQur Corporation | 1 | $49 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, Cologuard Collection Kit, REXULTI, Ozempic, UBRELVY, CeQur Simplicity.
Industry payments across TN — which companies pay providers there.
